GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Akeso 9926.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

88.70

+4.05%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥3.47bn

FY2018FY2025

Net income

−CN¥1.26bn

FY2018FY2025

Free cash flow

−CN¥2.13bn

FY2018FY2025

Shareholders' equity

CN¥10.56bn

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueCN¥3.47bnCN¥2.12bnCN¥4.53bnCN¥976.8mCN¥263.1m—CN¥70.9mCN¥2.8m
Gross profitCN¥2.73bnCN¥1.83bnCN¥4.39bnCN¥856.5mCN¥226.7m−CN¥1.9mCN¥70.9mCN¥2.8m
Research and developmentCN¥1.79bnCN¥1.19bnCN¥1.25bnCN¥1.54bnCN¥1.31bnCN¥768.6mCN¥308.4mCN¥161.1m
Operating income−CN¥1.07bn−CN¥570.4mCN¥2.04bn−CN¥1.63bn−CN¥1.46bn−CN¥1.02bn−CN¥340.7m−CN¥154.0m
Net income−CN¥1.26bn−CN¥514.5mCN¥2.03bn−CN¥1.36bn−CN¥1.25bn−CN¥1.04bn−CN¥335.4m−CN¥140.1m
Diluted earnings per share-1.39-0.602.42-1.63-1.53-1.32-1.63-0.18

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsCN¥18.67bnCN¥14.87bnCN¥10.71bnCN¥6.41bnCN¥5.60bnCN¥3.86bnCN¥1.67bnCN¥651.7m
Cash and short-term investmentsCN¥10.70bnCN¥8.53bnCN¥5.69bnCN¥2.67bnCN¥3.08bnCN¥2.79bnCN¥1.19bnCN¥413.8m
Total liabilitiesCN¥8.23bnCN¥7.00bnCN¥5.44bnCN¥3.44bnCN¥1.78bnCN¥405.7mCN¥1.46bnCN¥163.6m
DebtCN¥5.31bnCN¥3.95bnCN¥2.99bnCN¥1.88bnCN¥859.4mCN¥199.0mCN¥1.32bnCN¥65.0m
Shareholders' equityCN¥10.56bnCN¥7.95bnCN¥5.47bnCN¥3.07bnCN¥3.69bnCN¥3.19bn−CN¥6.4mCN¥441.2m
Shares outstanding911m857m838m836m817m787m206m763m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−CN¥1.30bn−CN¥527.6mCN¥2.88bn−CN¥1.45bn−CN¥1.17bn−CN¥617.8m−CN¥219.6m−CN¥123.4m
Capital spending−CN¥830.4m−CN¥585.8m−CN¥1.03bn−CN¥904.5m−CN¥830.4m−CN¥444.3m−CN¥136.3m−CN¥74.2m
Free cash flow−CN¥2.13bn−CN¥1.11bnCN¥1.85bn−CN¥2.35bn−CN¥2.00bn−CN¥1.06bn−CN¥355.9m−CN¥197.6m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥2.08bnCN¥1.89bnCN¥1.65bnCN¥1.10bnCN¥1.02bnCN¥849.4mCN¥4.29bnCN¥786.6m
Gross profitCN¥1.54bnCN¥1.47bnCN¥1.31bnCN¥897.3mCN¥937.6mCN¥790.5mCN¥4.20bnCN¥699.5m
Operating income−CN¥324.8m−CN¥561.0m−CN¥483.3m−CN¥285.8m−CN¥272.4m−CN¥436.7mCN¥2.71bn−CN¥921.8m
Net income−CN¥487.9m−CN¥622.6m−CN¥664.8m−CN¥275.9m−CN¥238.6m−CN¥496.7mCN¥2.94bn−CN¥627.3m
Diluted earnings per share-0.53-0.68-0.73-0.32-0.28-0.593.51-0.75
Cash from operationsCN¥338.0m−CN¥992.0m−CN¥265.0m−CN¥181.0m−CN¥346.0m−CN¥470.0mCN¥3.35bn−CN¥769.0m
Capital spending—−CN¥335.0m−CN¥560.0m−CN¥244.0m−CN¥244.0m−CN¥432.0m−CN¥406.0m−CN¥558.0m
Free cash flow—−CN¥1.33bn−CN¥825.0m−CN¥425.0m−CN¥590.0m−CN¥902.0mCN¥2.94bn−CN¥1.33bn
Total assetsCN¥18.91bnCN¥18.67bnCN¥15.49bnCN¥12.75bnCN¥10.46bnCN¥9.18bnCN¥11.33bnCN¥7.20bn
Cash and short-term investmentsCN¥10.68bnCN¥10.70bnCN¥8.32bnCN¥7.32bnCN¥2.98bnCN¥4.89bnCN¥6.78bnCN¥3.00bn
DebtCN¥1.15bnCN¥5.31bnCN¥5.30bnCN¥3.95bnCN¥3.32bnCN¥2.99bnCN¥2.97bnCN¥2.19bn
Shareholders' equityCN¥9.89bnCN¥10.56bnCN¥7.50bnCN¥6.81bnCN¥5.23bnCN¥4.69bnCN¥6.51bnCN¥3.45bn

Financial ratios

Data as of 10 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin78.7%86.4%97.1%87.7%86.1%—100.0%
Operating margin-30.8%-26.9%45.2%-167.2%-553.0%—-480.7%
Net margin-36.4%-24.2%44.8%-139.5%-476.4%—-473.2%
Return on equity-12.0%-7.6%43.2%-44.3%-34.0%-32.5%—
Return on assets-6.8%-4.0%22.1%-21.3%-22.4%-26.9%—
Free cash flow yield-0.5%0.1%4.3%-0.6%-0.4%-0.2%—
Revenue growth40.2%-53.1%440.3%271.3%——2408.1%
Earnings growth110.7%-125.4%-273.6%8.7%3.7%209.0%—
Current ratio5.14x5.15x4.71x2.25x4.81x17.66x—
Debt to equity0.50x0.58x0.64x0.71x0.27x0.06x—
Equity ratio56.5%53.4%51.1%48.0%65.8%82.6%—
Interest coverage-7.20x-8.36x23.50x-32.36x-120.53x-128.16x—
R&D as a share of sales51.5%55.9%27.7%158.0%497.7%—435.1%
Buybacks as a share of market value-6.3%-2.3%-0.3%-2.3%-3.8%-282.3%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue52.6%——
Operating income-13.1%0.9%—
Net income-2.5%4.1%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin81.6%88.4%——
Operating margin-29.3%-11.1%——
Net margin-31.8%-10.0%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-70.6-87.516.6-22.9-19.2-25.1
Price to sales25.721.27.431.991.5—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.